Results 11 to 20 of about 117,953 (306)

Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy [PDF]

open access: yesLiver Transplantation, 2016
Treatment options for refractory hepatic encephalopathy (HE) are limited. Patients who fail medical management may harbor large portosystemic shunts (PSSs) which are possible therapeutic targets. This study aims to describe patient selection, effectiveness, and safety of percutaneous PSS embolization in those with medically refractory HE.
Amir, Kashani   +6 more
openaire   +4 more sources

Unusual extrusion of distal end of ventriculoperitoneal shunt: Case series with literature review

open access: yesInterdisciplinary Neurosurgery, 2021
Background: Ventriculoperitoneal shunting is most common treatment for hydrocephalus. Ventriculoperitoneal (VP) shunt has been associated with complications from cerebral ventricles to peritoneal cavity [1].
Virendra Deo Sinha   +3 more
doaj   +1 more source

Transjugular intrahepatic portosystemic shunt for the treatment of medically refractory ascites [PDF]

open access: yesDiagnostic and Interventional Radiology, 2013
This study was performed to assess the safety, efficacy, and clinical outcomes of transjugular intrahepatic portosystemic shunt (TIPS) creation for treatment of medically refractory ascites and to identify prognostic factors for clinical response, morbidity, and mortality.In this retrospective study, 80 patients (male:female, 52:28; mean age, 56 years;
Ahmad Parvinian,   +4 more
openaire   +3 more sources

A Prospective Study and Analysis of Ventriculoperitoneal Shunt Surgery: Their Indication and Complication in a Single Tertiary Care Center

open access: yesIndian Journal of Neurosurgery, 2022
Backgroundā€ƒVentriculoperitoneal (VP) shunt insertion is routinely performed for the treatment of hydrocephalus due to different indications like congenital, infective, tumor, posttraumatic, and normal pressure hydrocephalus (NPH).
Barnava Pal   +8 more
doaj   +1 more source

Shunt quantification in congenital heart disease based on two-dimensional speckle tracking [PDF]

open access: yes, 2012
In this work we investigated how high frame rate speckle tracking based on plane wave imaging could be used to improve the quantification of peak velocities in shunt flows due to septal defects.
Fadnes, Solveig   +4 more
core   +2 more sources

Positional cyanosis reveals platypnea-orthodeoxia-syndrome

open access: yesRespiratory Medicine Case Reports, 2019
Platypnea-orthodeoxia syndrome is a rare cause of dyspnea, which presents upon standing and resolves when supine. Etiology is multifactorial with a functional component and an anatomical shunt. The most commonly reported shunt is an atrial septal defect,
Colin M. Kenny   +3 more
doaj   +1 more source

Colectomy for porto-systemic encephalopathy: is it still topical?

open access: yesClinics and Practice, 2013
Hepatic encephalopathy (HE) is a common long term complication of porto-systemic shunt. We report herein the case of a 59-year-old man with Child-Pugh A cirrhosis treated successfully 9 years earlier with distal splenorenal shunt for uncontrolled ...
Rym Ennaifer   +5 more
doaj   +1 more source

TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update [PDF]

open access: yes, 2010
Refractory ascites is a frequent complication of advanced cirrhosis and is associated with hepatorenal syndrome and hepatic hydrothorax. Large volume paracentesis and pleurodesis are regarded as first-line treatments in patients who do not respond ...
Gerbes, Alexander L., Roessle, Martin
core   +1 more source

SILICONE TUBE SHUNT IN SUPRACHOROIDAL SPACE IN RECALCITRANC GLAUCOMAS

open access: yesJournal of Nepal Medical Association, 2003
Silicone tube shunt operations to drain the aqueous from the anterior chamber to the suprachoroidal space were performed in 12 different types of refractory glaucomas in which the intraocular pressure ranged from 25 mmHg to 80 mmHg (mean 45.75 mmHg) even
K JD Karki, A Momose
doaj   +1 more source

Transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A phase 2, randomized, sham-controlled trial [PDF]

open access: yes, 2018
Background -In non-randomized, open-label studies, a transcatheter interatrial shunt device (IASD, Corvia Medical) was associated with lower pulmonary capillary wedge pressure (PCWP), less symptoms, and greater quality of life and exercise capacity in ...
Basuray, Anupam   +17 more
core   +1 more source

Home - About - Disclaimer - Privacy